EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Monomeric C-Reactive Protein in Atherosclerotic Cardiovascular Disease: Advances and Perspectives

Ivan Melnikov iD, Sergey Kozlov iD, Olga Saburova, Yuliya Avtaeva iD, Konstantin Guria, Zufar Gabbasov

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24032079 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Ivan Melnikov und 5 weiteren Autor:innen. Beteiligte Einrichtung: National Medical Research Centre of Cardiology Named after Academician E.I. Chazov, Ministry of Health of the Russian Federation, 15A 3-rd Cherepkovs…. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Atherosclerosis. Die Arbeit wurde bisher 50-mal zitiert (Crossref) und nennt 159 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This review aimed to trace the inflammatory pathway from the NLRP3 inflammasome to monomeric C-reactive protein (mCRP) in atherosclerotic cardiovascular disease. CRP is the final product of the interleukin (IL)-1β/IL-6/CRP axis. Its monomeric form can be produced at sites of local inflammation through the dissociation of pentameric CRP and, to some extent, local synthesis. mCRP has a distinct proinflammatory profile. In vitro and animal-model studies have suggested a role for mCRP in: platelet activation, adhesion, and aggregation; endothelial activation; leukocyte recruitment and polarization; foam-cell formation; and neovascularization. mCRP has been shown to deposit in atherosclerotic plaques and damaged tissues. In recent years, the first published papers have reported the development and application of mCRP assays. Principally, these studies demonstrated the feasibility of measuring mCRP levels. With recent advances in detection techniques and the introduction of first assays, mCRP-level measurement should become more accessible and widely used. To date, anti-inflammatory therapy in atherosclerosis has targeted the NLRP3 inflammasome and upstream links of the IL-1β/IL-6/CRP axis. Large clinical trials have provided sufficient evidence to support this strategy. However, few compounds target CRP. Studies on these agents are limited to animal models or small clinical trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiovascular DiseasesAtherosclerosisAnimalsC-Reactive ProteinInflammasomesInterleukin-6NLR Family, Pyrin Domain-Containing 3 ProteinInflammation

Stichwörter der Autor:innen

C-reactive proteinatherosclerosisbiomarkerinflammationmCRPmonomeric C-reactive proteinresidual inflammatory riskthromboinflammation

Substanzen

C-Reactive ProteinInflammasomesInterleukin-6NLR Family, Pyrin Domain-Containing 3 Protein

Autor:innen und Institutionen

  • National Medical Research Centre of Cardiology Named after Academician E.I. Chazov, Ministry of Health of the Russian Federation, 15A 3-rd Cherepkovskaya Street, 121552 Moscow, Russia.
  • State Research Center of the Russian Federation, Institute of Biomedical Problems of Russian Academy of Sciences, 76A Khoroshevskoye Shosse, 123007 Moscow, Russia.

ORCID-Profile: Ivan Melnikov, Sergey Kozlov, Yuliya Avtaeva

Förderung

  • Russian Science Foundation

Zitieren

APA

Melnikov, I., Kozlov, S., Saburova, O., Avtaeva, Y., Guria, K., & Gabbasov, Z. (2023). Monomeric C-Reactive Protein in Atherosclerotic Cardiovascular Disease: Advances and Perspectives. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24032079

Vancouver

Melnikov I, Kozlov S, Saburova O, Avtaeva Y, Guria K, Gabbasov Z. Monomeric C-Reactive Protein in Atherosclerotic Cardiovascular Disease: Advances and Perspectives. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24032079

BibTeX
@article{Melnikov2023,
  author = {Melnikov, Ivan and Kozlov, Sergey and Saburova, Olga and Avtaeva, Yuliya and Guria, Konstantin and Gabbasov, Zufar},
  title = {Monomeric C-Reactive Protein in Atherosclerotic Cardiovascular Disease: Advances and Perspectives},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24032079}
}
Kostenlos starten →